1. Homepage
  2. Equities
  3. Malaysia
  4. BURSA MALAYSIA
  5. IHH Healthcare Berhad
  6. News
  7. Summary
    IHH   MYL5225OO007

IHH HEALTHCARE BERHAD

(IHH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

IHH Healthcare Issues Over 2 Million New Shares to Option Holders

12/14/2021 | 04:22am EDT


© MT Newswires 2021
All news about IHH HEALTHCARE BERHAD
04/20PAUL RAMSAY : KKR-led group offers record $14.8 billion bid for Australia's Ramsay Health
RE
04/19Ramsay Health Shares Jump 30% Following KKR-Led Proposal
DJ
04/14EKO.AI. announced that it has received $15 million in funding from IHH Healthcare Berha..
CI
03/29IHH Healthcare to Seek Shareholders' Approval to Renew Share Buyback Mandate
MT
03/23IHH Healthcare Offers to Buy Ramsay-Sime Darby Health Care JV for $1.3 Billion
MT
03/22Ramsay Health Care, Sime Darby Confirm Receipt of $1.35 Billion Offer for JV
MT
03/22IHH Healthcare Confirms Proposal to Buy Ramsay Sime Darby for Over $1 Billion
MT
03/22Malaysia's IHH Healthcare offers $1.35 billion for Ramsay-Sime Darby JV
RE
03/21Ramsay Health, Sime Receive Conditional Proposal for Asian JV
DJ
03/21IHH Healthcare Berhad Appoints Tomo Nagahiro as Non Independent and Non Executive Alter..
CI
More news
Financials
Sales 2022 17 983 M 4 087 M 4 087 M
Net income 2022 1 609 M 366 M 366 M
Net Debt 2022 3 542 M 805 M 805 M
P/E ratio 2022 35,7x
Yield 2022 1,08%
Capitalization 57 922 M 13 165 M 13 165 M
EV / Sales 2022 3,42x
EV / Sales 2023 3,12x
Nbr of Employees 65 000
Free-Float 45,4%
Chart IHH HEALTHCARE BERHAD
Duration : Period :
IHH Healthcare Berhad Technical Analysis Chart | IHH | MYL5225OO007 | MarketScreener
Technical analysis trends IHH HEALTHCARE BERHAD
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Last Close Price 6,58 MYR
Average target price 7,46 MYR
Spread / Average Target 13,3%
EPS Revisions
Managers and Directors
Chi Keon Loh CEO, MD & Non-Independent Executive Director
Joerg Ayrle Group Chief Financial Officer
Mohammed Azlan bin Hashim Independent Non-Executive Chairman
Heng Joo Sim Group Chief Operating Officer
Jill Margaret Watts Independent Non-Executive Director